Glanbia plc (GLAPY)
Market Cap | 3.65B |
Revenue (ttm) | 3.84B |
Net Income (ttm) | 164.70M |
Shares Out | n/a |
EPS (ttm) | 0.62 |
PE Ratio | 22.15 |
Forward PE | 11.09 |
Dividend | 2.12 (2.98%) |
Ex-Dividend Date | Mar 21, 2025 |
Volume | 114 |
Average Volume | 1,988 |
Open | 71.00 |
Previous Close | n/a |
Day's Range | 71.00 - 71.00 |
52-Week Range | 52.40 - 84.30 |
Beta | 0.66 |
RSI | 49.09 |
Earnings Date | Aug 13, 2025 |
About Glanbia
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; pro... [Read more]
Financial Performance
In 2024, Glanbia's revenue was $3.84 billion, a decrease of -29.23% compared to the previous year's $5.43 billion. Earnings were $164.70 million, a decrease of -52.18%.
Financial StatementsNews
Glanbia Performance Nutrition and Opinions scoop top prize at MII All Ireland Marketing Awards
Glanbia Performance Nutrition in partnership with research company Opinions scooped the Grand Prix at the Marketing Institute Ireland (MII) All-Ireland Marketing Awards last night.
Tirln pushes ahead with Glanbia share spin-out to members
Tirlns board has announced a spin-out of shares in stock market-listed Glanbia from the co-op to individual members.

Flax Protein Markets and Companies Analysis Report 2025 with Forecasts to 2029 & 2034 - Featuring Glanbia Nutritionals, Grain Millers, Myprotein, Linwoods Health Foods, Bioriginal Food & Science Corp. and More
Explore the booming Flax Protein Market: projected to soar from $38.54B in 2024 to $56.42B by 2029, driven by the rise in plant-based diets and demand for minimally processed foods. Explore the boomin...
Wellness gains, shareholder pains: Glanbias structure under fire
Glanbia may be well positioned to ride the global wellness wave, but a growing number of its shareholders are questioning whether the companys current structure is the right vehicle to capitalise on i...

Glanbia shares jump after 'better than feared' first quarter
Shares in nutrition supplement maker Glanbia jumped 10% on Wednesday after analysts pointed to a "better than feared" first quarter performance that allowed the Irish group to maintain its full year e...

Glanbia plc (GLAPF) 2024 Full Year Results Earnings Call Transcript
Glanbia plc (OTCPK:GLAPF) 2024 Full Year Results Earnings Conference Call February 26, 2025 3:30 AM ET Company Participants Liam Hennigan – Group Secretary and Head of Investor Relations Hugh McGuire ...

Supplements producer Glanbia's shares dive on profit warning
Shares in nutrition supplement maker Glanbia slid by 15% on Wednesday after it warned that it expects earnings to fall by up to 11% this year, hit by a longer than expected rise in the cost of whey, a...

Glanbia plc (GLAPF) Q2 2024 Earnings Call Transcript
Glanbia plc (OTCPK:GLAPF) Q2 2024 Earnings Conference Call August 14, 2024 3:30 AM ET Company Participants Liam Hennigan - Investor Relations Hugh McGuire - Chief Executive Officer Mark Garvey - Chief...

Glanbia plc (GLAPF) Q4 2023 Earnings Call Transcript
Glanbia plc (GLAPF) Q4 2023 Earnings Call Transcript

Glanbia: Fairly Valued For Current Performance
Glanbia has seen a 47% increase in value since August 2020, with its US nutrition business continuing to perform well. Profitability has been less impressive, with a net profit margin of 3.5% and post...

Glanbia plc (GLAPF) Q2 2023 Earnings Call Transcript
Glanbia plc (OTCPK:GLAPF) Q2 2023 Results Conference Call August 16, 2023 3:30 AM ET Company Participants Liam Hennigan - Group Secretary & Head-IR Siobhan Talbot - Group Managing Director Mark Garvey...

Glanbia plc (GLAPF) Q4 2022 Earnings Call Transcript
Glanbia plc (OTCPK:GLAPF) Q4 2022 Earnings Conference Call March 1, 2023 3:30 AM ET Company Participants Liam Hennigan - Secretary and Head of IR Siobhan Talbot - Group Managing Director Mark Garvey -...

Glanbia plc's (GLAPF) Q4 2021 Results - Earnings Call Transcript
Glanbia plc's (GLAPF) Q4 2021 Results - Earnings Call Transcript

Glanbia plc (GLAPF) Q2 2021 Results - Earnings Call Transcript
Glanbia plc (GLAPF) Q2 2021 Results - Earnings Call Transcript

Glanbia PLC (GLAPF) on Q4 2020 Results - Earnings Call Transcript
Glanbia PLC (GLAPF) on Q4 2020 Results - Earnings Call Transcript

Glanbia: A Name To Play The U.S. Nutrition Market
Glanbia is a London-listed Irish company but actually makes most of its money from U.S. nutrition businesses.